Safety and Efficacy of Autologous Umbilical Cord Blood Stem Cells Infusion for Preterm Infants.
Status:
Not yet recruiting
Trial end date:
2021-03-01
Target enrollment:
Participant gender:
Summary
This study aims to establish a multidisciplinary collaboration platform for autologous cord
blood stem cell therapy in premature infants in Guangdong Province; to develop autologous
cord blood collection and cell preparation operation procedures for premature infants; to
conduct multi-center clinical research, to establish a safety and effectiveness evaluation
system; and to explore the mechanism of action. This project will solve the bottleneck
problem in the treatment of premature infants once the clinical application is successfully
transformed.